HLX48

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLX48, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors [Phase 1]

See pricing